Antibiotics

This specific rationale is not well supported, and it may be backwards. A prominent BMJ analysis argued that the 'complete the course' message rests on little evidence, and that for many infections longer exposure drives more resistance, not less — shorter courses are increasingly shown to work just as well. Two cautions keep this honest. First, this is an argument about the RESISTANCE justification, not a licence to stop the moment you feel better and self-manage: the current, correct advice is to take antibiotics exactly as prescribed, because the right duration is the one your clinician chose for your infection, and for some infections (tuberculosis is the clearest) completion genuinely does matter. Second, changing course length is a decision for the prescriber, not the patient. So: follow the instructions you were given — but the folk belief that a fixed 'full course' is a law of nature protecting the world from resistance is not one.

It can, in several concrete ways. An antibiotic course roughly doubles your own chance of carrying resistant bacteria for the following months (in urinary bacteria, odds about 2.5-fold within two months, still raised at a year). Antibiotics are the leading modifiable cause of Clostridioides difficile, a serious gut infection — the risk is highest with clindamycin, cephalosporins and fluoroquinolones. They disrupt the gut microbiome, which mostly but not fully recovers: in one study, nine common gut species were still undetectable six months after a short course. Allergic reactions range from rash to anaphylaxis, and specific classes carry specific dangers — fluoroquinolones alone carry FDA boxed warnings for tendon rupture, aortic aneurysm and dissection, nerve damage and serious mental-health effects. 'Just in case' is not a free action.

Very possibly you can. About one in ten people carries a penicillin-allergy label, but when those people are formally assessed, the large majority — well over 90% — are not truly allergic; genuine penicillin hypersensitivity affects under 5%. Many labels come from a childhood rash that was the infection, not the drug, and true allergy also fades: around 80% of genuinely allergic people tolerate penicillin again after a decade. This matters because the label is not harmless — it pushes people onto broader, less effective, and sometimes more dangerous alternatives, and is associated with more MRSA and C. difficile. An incorrect penicillin-allergy label is worth having formally re-evaluated rather than carried for life. (A label that followed a severe reaction — swelling, breathing difficulty, blistering — is different and must be taken seriously; this is a conversation for a clinician, not a decision to make alone.)

Rarely enough to be worth it. Most acute sinusitis is viral or self-limiting: in trials, about 46% of people are better within a week and 64% within two weeks with no antibiotic at all. Antibiotics add only a small absolute benefit — roughly one extra person cured for every 17 treated — while causing side effects in about one in eight, so across a typical group the harm outweighs the benefit. Guidelines reserve antibiotics for the minority with features suggesting bacterial infection (severe, prolonged, or 'double-sickening' illness that improves then clearly worsens). For most people with a blocked, painful few days, the honest answer is that antibiotics are not the treatment, and symptom relief plus time is.

Your own prescriptions affect your own body, directly and measurably. A systematic review found that an individual who takes an antibiotic in primary care is left with a substantially higher chance of carrying resistant bacteria — the effect is strongest in the first month and still detectable up to a year later. Scaled across a population, that is the engine of resistance: an estimated 1.27 million deaths worldwide in 2019 were directly attributable to bacterial antimicrobial resistance, and nearly five million were associated with it. Roughly 30% of outpatient antibiotic prescriptions are estimated to be unnecessary. Resistance is not only a hospital's problem or a future one — it is a cumulative consequence of ordinary prescribing, which is exactly why using antibiotics only when they will help is framed as a shared responsibility rather than an individual inconvenience.

Usually not. Most sore throats are viral, and even when antibiotics are given they shorten symptoms by only about 16 hours on average. Their real value is narrower: reducing the uncommon complications of streptococcal (strep) throat — acute rheumatic fever and abscess — which is why clinicians use scoring tools to estimate the chance of a bacterial cause before prescribing, rather than treating every sore throat. In settings where rheumatic fever is rare, most sore throats are managed with pain relief and time. The question is not whether the throat hurts; it is whether the cause is the bacterium antibiotics act on.